Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.3B | 1.3B | 1.2B | 1.2B |
Cost of revenue | 1.0B | 1.1B | 1.0B | 991M |
Gross profit | 279M | 225M | 214M | 235M |
Operating expense | ||||
Research & development | 20M | 16M | 17M | 17M |
Selling general and admin | 113M | 163M | 120M | 119M |
Other operating expenses | — | — | — | — |
Operating income | 129M | 27M | 58M | 80M |
Non operating interest income | ||||
Income | — | — | 15M | 17M |
Expense | 14M | 15M | 15M | 16M |
Other income expense | — | — | — | — |
Pretax income | 115M | -37M | 58M | 81M |
Tax provision | 30M | -14M | 13M | 21M |
Net income | 85M | -23M | 45M | 60M |
Basic EPS | 1.7 | -0.5 | 0.9 | 1.2 |
Diluted EPS | 1.7 | -0.5 | 0.9 | 1.2 |
Basic average shares | 49M | 50M | 50M | 50M |
Diluted average shares | 49M | 50M | 50M | 51M |
EBITDA | 148M | 4M | 93M | 117M |
Net income from continuing op. | 85M | -23M | 44M | 61M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |